Latest news

Year end trading update

Trading for FY22 was materially ahead of market expectations. The Company performed strongly with its flagship product Bleepa® contributing an increasing proportion of total revenue. The Company will provide further information at the time of its full year results announcement, expected in September 2022.

16 June 2022

Bleepa wins two NHS contract awards

Two twelve-month contracts awarded to provide Bleepa across two NHS Trusts.

12 April 2022

Bleepa TB screening pilot now live in Odisha

The impact of this technology means that TB screening can now be expanded to rural areas where digital imaging was difficult to deliver, enabling current TB screening services to reach more people.

31 March 2022

Bleepa one of DIT Digital Health First 100 companies

Bleepa is one of 100 companies featured in the Department for International Trade‘s (DIT) Digital Health First 100 Companies playbook, launched on Wednesday 24 February 2021. With UK companies at the heart of technologies that offer accessible, affordable and sustainable care, the DIT is promoting British innovators in digital health who are ready to go global and link it with an ever expanding worldwide opportunity.

25 February 2022

Feedback’s interim results published

Feedback PLC, Bleepa's parent company, has announced its unaudited interim results for the six months to 30 November 2021.

10 February 2022